Baumgarten Janosch, Schneider Philipp, Thiemann Marie, Zimmermann Moritz, Diederich Christina, Blankenfeldt Wulf, Kunick Conrad
Institut für Medizinische und Pharmazeutische Chemie, Technische Universität Braunschweig, Beethovenstraße 55, Braunschweig, 38106, Germany.
Center of Pharmaceutical Engineering (PVZ), Technische Universität Braunschweig, Franz-Liszt-Str. 35a, Braunschweig, 38106, Germany.
ChemMedChem. 2024 Dec 16;19(24):e202400466. doi: 10.1002/cmdc.202400466. Epub 2024 Oct 29.
The phenazine pyocyanin is an important virulence factor of the pathogen Pseudomonas aeruginosa, which is on the WHO list of antibiotic resistant "priority pathogens". In this study the isomerase PhzF, a key bacterial enzyme of the pyocyanin biosynthetic pathway, was investigated as a pathoblocker target. The aim of the pathoblocker strategy is to reduce the virulence of the pathogen without killing it, thus preventing the rapid development of resistance. Based on crystal structures of PhzF, derivatives of the inhibitor 3-hydroxyanthranilic acid were designed. Co-crystal structures of the synthesized derivatives with PhzF revealed spacial limitations of the binding pocket of PhzF in the closed conformation. In contrast, ligands aligned to the open conformation of PhzF provided more room for structural modifications. The intrinsic fluorescence of small 3-hydroxyanthranilic acid derivatives enabled direct affinity determinations using FRET assays. The analysis of structure-activity relationships showed that the carboxylic acid moiety is essential for binding to the target enzyme. The results of this study provide fundamental structural insights that will be useful for the design of PhzF-inhibitors.
吩嗪绿脓菌素是病原体铜绿假单胞菌的一种重要毒力因子,该菌位列世界卫生组织抗生素耐药“重点病原体”名单。在本研究中,异构酶PhzF作为绿脓菌素生物合成途径中的一种关键细菌酶,被作为致病阻断靶点进行研究。致病阻断策略的目的是降低病原体的毒力而不将其杀死,从而防止耐药性的快速产生。基于PhzF的晶体结构,设计了抑制剂3-羟基邻氨基苯甲酸的衍生物。合成衍生物与PhzF的共晶体结构揭示了PhzF在闭合构象时结合口袋的空间限制。相比之下,与PhzF开放构象对齐的配体为结构修饰提供了更多空间。小的3-羟基邻氨基苯甲酸衍生物的固有荧光使得能够使用荧光共振能量转移(FRET)测定法直接进行亲和力测定。构效关系分析表明,羧酸部分对于与靶酶结合至关重要。本研究结果提供了重要的结构见解,将有助于设计PhzF抑制剂。